REQUEST A DEMO
Total
USD $0.00
Search more companies

Astron Pharmaceuticals Private Limited (India)

Main Activities: Office Administrative Services
Full name: Astron Pharmaceuticals Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Astron Pharmaceuticals Private Limited is based in India. The head office is in Shahdara. The company operates in the Office Administrative Services sector. The enterprise was incorporated on March 02, 1989. In 2025, the company reported a net sales revenue increase of 14.71%. Its’ total assets recorded a growth of 29.94%. The net profit margin of Astron Pharmaceuticals Private Limited decreased by 0.21% in 2025.

Legal Address
0-1Hansa Apartments
Shahdara; Delhi; Postal Code: 110032

Contact Details: Purchase the Astron Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Astron Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Astron Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
March 02, 1989
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Astron Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
14.71%
Total Operating Revenue
14.71%
Operating Profit
25.55%
EBITDA
32.94%
Net Profit/Loss for the Period
-7.26%
Total Assets
29.94%
Total Equity
15.48%
Operating Profit Margin
0.22%
Net Profit Margin
-0.21%
Return on Equity (ROE)
-3.29%
Debt / Equity
49.06%
Quick Ratio
-0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?